Companies / Malaysia
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Kotra Surveys Horizon
July 2007 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Confirming BMI's predicted trend for Malaysian drugmakers to look abroad for growth, Kotra Pharma has unveiled a 5-year plan that focuses on exports, initially to neighbouring ASEAN countries, but ultimately to the lucrative markets of Western Europe and the US. To achieve this goal, the company intends to expand production capabilities, increase R&D investment, attract world-class talent and enlarge its product portfolio. BMI wholly concurs with Kotra's strategy, especially considering the limited opportunities in its US$1.1bn domestic